
Marc Sharfman, MD
Advertisement
Articles by Marc Sharfman, MD

Advertisement
Advertisement
Advertisement
Trending on AJMC
1
CDC Officially Ends Hantavirus Response as Outbreak Risk Recedes
2
FDA Approves Palbociclib for HR+, HER2+ Breast Cancer Maintenance
3
ATTR-CM Incidence, Prevalence Rose Sharply in the US
4
Zanubrutinib Tops Rivals in Real-World CLL Survival Study
5